Cepheid (CPHD) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free CPHD Stock Alerts Notice: Cepheid stock has been delisted and is no longer actively trading. Cepheid is now a division of Danaher Corporation (NYSE:DHR). Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIn The Fight To End Tuberculosis, This Is The Moment For Progressforbes.com - November 15 at 7:55 PMReducing the spread of hepatitis Cbbc.com - July 22 at 3:39 PMSpotSee Forms Life Science Advisory Council with Global Industry Leadersit.tmcnet.com - June 27 at 12:18 PMCepheid (CPHD) Showing Signs Of Being Water-Logged And Getting Wetterthestreet.com - May 14 at 1:00 AMGlobal Biochips Market Research Report 2022: Market to Surpass $25+ Billion by 2026 - ResearchAndMarkets.com - Business Wirebusinesswire.com - October 13 at 1:34 PMThe Worldwide Infectious Disease In Vitro Diagnostics Industry is Expected to Reach $56.6 Billion by 2030 - ResearchAndMarkets.com - Business Wirebusinesswire.com - October 7 at 4:10 PMGlobal Infectious Disease In Vitro Diagnostics Market Report (2022 to 2030) - High Demand for PoC Facilit - Benzingabenzinga.com - October 7 at 11:04 AMGlobal COVID-19 Testing Industry - GlobeNewswireglobenewswire.com - October 6 at 8:39 AMLucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays - GlobeNewswireglobenewswire.com - September 30 at 11:19 PMKey Reasons to Retain Danaher (DHR) Stock in Your Portfolio - Nasdaqnasdaq.com - September 30 at 6:09 PMLucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays - Yahoo Financefinance.yahoo.com - September 29 at 5:06 PMLucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays - StreetInsider.comstreetinsider.com - September 29 at 12:05 PMSystemOne Wins Multi-Country, Multi-Device Subcontract through the Infectious Disease Detection and Surveillance Project - StreetInsider.comstreetinsider.com - September 28 at 9:03 PMGlobal Oncology Molecular Diagnostics Market Report 2022: A $7.28 Billion Market by 2027 - Rise in Demand for Point-of-care Treatment - PR Newswireprnewswire.com - September 20 at 4:55 PMWorldwide Tuberculosis Diagnosis and Treatment Industry to 2028 - by Diagnosis, Drugs, End-user and Region - ResearchAndMarkets.com - Business Wirebusinesswire.com - September 16 at 11:55 AMDanaher (DHR) to Spin-Off Environmental Unit, Shares Pop - Nasdaqnasdaq.com - September 15 at 6:09 PMGlobal Oncology Molecular Diagnostics Markets, 2022-2027 - Rising Number of R&D Activities & Technological Advancements in Diagnostic Testing - ResearchAndMarkets.com - Business Wirebusinesswire.com - September 14 at 5:06 PMHow monkeypox could help Karius underscore case for its broad pathogen test - San Francisco Business Times - The Business Journalsbizjournals.com - September 2 at 6:27 PMWith 6.1% CAGR, Global Tuberculosis Diagnostics Market Size Worth USD 3.13 Billion during Forecast [2022-2029] - GlobeNewswireglobenewswire.com - August 29 at 6:55 PMWith 4.1% CAGR, Canada Sexually Transmitted Disease Testing Market Size worth USD 310.5 Million in 2028 - Report by Fortune Business Insights - GlobeNewswireglobenewswire.com - August 24 at 6:30 AMWeitz Analyst Corner: Danaher - GuruFocus.comgurufocus.com - August 17 at 6:06 PMGlobal Covid Diagnostics Market (2022 to 2027) - Launch of Innovative Products Presents Opportunities - ResearchAndMarkets.com - Business Wirebusinesswire.com - July 28 at 8:26 AMDanaher Corporation's (DHR) CEO Rainer Blair on Q2 2022 Results - Earnings Call Transcript - Seeking Alphaseekingalpha.com - July 23 at 9:09 AMGlobal COVID-19 Diagnostics Market Forecasts, 2022-2027: Time to Market and Preparedness Issues - PR Newswireprnewswire.com - July 22 at 1:25 PMCompanies In The COVID-19 Rapid Test Kits Market Help Ease - GlobeNewswireglobenewswire.com - July 6 at 4:49 PMPat Patrick to step down as Chamber president and CEO - Yahoo Newsnews.yahoo.com - June 17 at 7:06 PMSDI Presence Director Ric Mims Honored with HDI Lifetime Achievement Award - Yahoo Financefinance.yahoo.com - June 16 at 10:46 PMHave Scientists Found A ‘Mirror World’ Parallel Universe That Explains Everything? The Truth Behind The Headlines - Forbesforbes.com - June 13 at 10:34 PMSexually Transmitted Diseases Diagnostics Market is Expected to Reach USD 6.4 billion by 2032 | Sexually Transmitted Diseases Diagnostics Industry Technology, Trends, Size, Share and Forecast - Yahoo Financefinance.yahoo.com - May 23 at 5:06 PMDNA Diagnostics Market to reach US$ 51.5 Billion by 2032, applications abound in Oncology: FMI Report - Yahoo Financefinance.yahoo.com - May 18 at 8:32 AMDNA Diagnostics Market to reach US$ 51.5 Billion by 2032, applications abound in Oncology: FMI Report - GlobeNewswireglobenewswire.com - May 17 at 1:34 AMCepheid Receives Emergency Use Authorization for Xpert® Xpress CoV-2 plus - PR Newswireprnewswire.com - May 12 at 10:16 AMClinical Microbiology Market Research Report by Product, Source, Specimen Type, End User, Application, Re - Benzingabenzinga.com - May 10 at 8:14 AMThe top Influenza Diagnostics Market Players take over almost half of the total industry! Learn what they do right - PR Newswireprnewswire.com - May 5 at 8:52 PMThe top Influenza Diagnostics Market Players take over almost half of the total industry! Learn what they do right - Yahoo Financefinance.yahoo.com - May 5 at 3:46 PMNorth America Precision Medicine Market size to surpass $50bn by 2027, says Graphical Research - Yahoo Financefinance.yahoo.com - May 2 at 8:11 AMInfluenza Diagnostics Market Demand Is Better Met With Government Policies and Collaborations - TBRC - Yahoo Financefinance.yahoo.com - March 16 at 1:36 PMStarwatch: the Garnet Star, Cepheus’s red gem, is a thing of beauty - The Guardiantheguardian.com - March 14 at 2:35 AM4 Stocks to Gain From the Promising Diversified Operations Industry - Yahoo Financefinance.yahoo.com - March 4 at 4:15 PMInsights on the Clinical Microbiology Global Market to 2027 - Featuring Alere, Cepheid and Danaher Among Others - ResearchAndMarkets.com - Business Wirebusinesswire.com - February 25 at 7:57 AMGlobal COVID-19 Diagnostics Market Report 2022: Market Size is Expected to Reach $283.93 Billion by 2029 - Benzingabenzinga.com - February 17 at 8:04 AMPersonalized Medicine Market to Reach USD 800 Billion by 2028 at a CAGR of 7% - Technological Advancements, Healthcare Benefits, Business Opportunities, Industry Insights and Statistical Forecast: Adroit Market Research - Yahoo Financefinance.yahoo.com - February 4 at 4:36 AMThis Under-the-Radar Industrial Stock Can Buy You Some Portfolio Protection - Motley Foolfool.com - February 3 at 8:19 AMGlobal Nasal Swab Test Market Size Is Expected To Reach Around USD 150.7 Million by 2026, at a CAGR of 3.4% Growth - GlobeNewswireglobenewswire.com - January 10 at 12:10 PMGlobal COVID-19 Rapid Test Kits Market Report 2021: Market is Expected to Reach $0.27 Billion in 2025 at a CAGR of -58% with Long-term Forecast to 2030 - Yahoo Financefinance.yahoo.com - December 10 at 3:16 PMTANK WORLDWIDE ANNOUNCES NEW EXECUTIVE LEADERSHIP TEAM - Yahoo Financefinance.yahoo.com - December 9 at 11:37 PMCOVID-19 Rapid Test Kits Global Market Report 2021 - ResearchAndMarkets.com - Yahoo Financefinance.yahoo.com - December 9 at 1:36 PMGlobal COVID-19 Rapid Test Kits Markets Report 2021: Rapid Antigen, Rapid Antibody, Equipment and Extraction Kits, RT-PCR Test Kits, Reagents - Yahoo Finance UKuk.finance.yahoo.com - December 9 at 8:36 AMGlobal Point of care Diagnostics Market Size [2021-2028] | to Reach USD 36.21 Billion by 2028 - GlobeNewswireglobenewswire.com - December 7 at 8:57 AMAutomated Microbiology Market Revenue Growth Driven by Increasing Need for More Reliable Results and Faster Turnaround Time: Reports and Data - PRNewswireprnewswire.com - December 6 at 1:17 PM Get Cepheid News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHD and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide CPHD Media Mentions By Week CPHD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPHD News Sentiment▼0.000.43▲Average News Sentiment CPHD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPHD Articles This Week▼00▲CPHD Articles Average Week Get Cepheid News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPHD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsKeep Your Eyes on This Power-Mad PoliticianAltimetryThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cepheid Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
